Nearly 1.9 billion shares and $33 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge.  Here are the bets being made today...   Read More

Traders will be glued to the web Thursday night as thousands of cancer studies go online. What’s the trade as these studies potentially send shock waves through biotech stocks on Friday morning?   Read More

Following are the day’s biggest winners and losers. Find out why shares of Dell and Fluor popped while True Religion and Western Refining dropped   Read More

It's a big day for pipeline progress...or not. Late Friday, Merck and Schering-Plough announced that the Food and Drug Administration won't approve their combo Claritin-Singulair combo pill for allergies.    Read More

In Wednesday’s Web Extra the traders reveal how to play Dell and a few of the pharmaceuticals.    Read More

Following are the day’s biggest winners and losers. Find out why shares of General Motors and Dillard's popped while VeriFone and Crocs dropped.   Read More

Investors seem to be shrugging off another setback for drug giant Pfizer. Late yesterday the company announced it's stopping a late-stage clinical trial for a skin cancer drug because it looks like it doesn't work better than chemo.    Read More